Response to Letter to the Editor From Han and Xu: "Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes"

J Clin Endocrinol Metab. 2023 Mar 10;108(4):e58-e59. doi: 10.1210/clinem/dgac697.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus*
  • Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
  • Humans
  • Hypoglycemic Agents
  • Incidence
  • Kidney Failure, Chronic* / epidemiology
  • Liver Cirrhosis / epidemiology
  • Neoplasms* / epidemiology

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents